About

About
The DS management team has both a strong background in developing drugs for the market and experience in building life science companies.

Pipeline

Pipeline
DS Biopharma have three novel assets in various stages of clinical and pre-clinical development and intend to add more bioactive lipids to the current portfolio in the coming years.

Investors

Investors
To date, DS Biopharma have been funded privately.

Latest News

August 23, 2016

DS Biopharma (DS) Announces Spin-Out Company Focused on Fibrotic Conditions and Pulmonary Disorders

Dublin, Ireland, 22 August 2016: DS Biopharma (DS), a privately held drug discovery and development company with industry-leading expertise in lipid science, today announces the launch […]
January 7, 2016

DS Biopharma announces positive top-line Phase IIa trial results for DS107 as an oral treatment for moderate to severe atopic dermatitis

Dublin, Ireland, January 7th, 2016 – DS Biopharma (DS), a privately held biopharmaceutical company, today announced positive top-line results from a Phase IIa clinical trial of […]

Join our mailing list

Connect with us